The changing payment and competition landscape in healthcare are the 2 biggest challenges facing community oncologists today, explained Robin Shah, vice president of Provider Marketing and Strategy at Flatiron Health.
The changing payment and competition landscape in healthcare are the 2 biggest challenges facing community oncologists today, explained Robin Shah, vice president of Provider Marketing and Strategy at Flatiron Health.
Transcript
What are the biggest challenges facing community oncologists that Flatiron Health is trying to help with?
So I would say 2 of the biggest challenges community oncologists face today are there’s a changing landscape from a payer perspective. So, right now, practices get paid 1 way and they’ve built their businesses to get paid in that way and these businesses are large and there’s a shift in payment for these massive business that they don’t have the support system, infrastructure and technology to help them operate in that new era of payment. So, the shift has been tectonic, where it’ll sort of buzz and then come back because the practices can’t handle it, and so, it’s sort of that point of which one of the practices are going to be able to make it through when the real shift does come. A real shift hasn’t come yet, it’s sort of been piecemeal, but we do think that it’ll come sooner than later and the smaller practices won’t be able to survive in this new market because they won’t have the infrastructure to operate. So that’s number one.
Number two is competition. As you have this shift, those that can handle that type of change, become bigger stronger better and those that can’t will continue to falter. As the larger groups, the ones that actually have the infrastructure are successful, they then become an engine to compete against the other groups. Right now, the systems that are capable of doing this are hospitals, specifically because the government has built a number of incentive programs for the hospitals to be sustainable. So, that is a complicated and difficult arena for community oncology providers unless there’s a shift in that government regulation that favors hospitals. That may or may not happen. Right now a lot of it is focused on payment, but how does an organization actually build the infrastructure around the new business models that are being created?
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More